{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T06:04:54Z","timestamp":1784613894585,"version":"3.55.0"},"reference-count":22,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T00:00:00Z","timestamp":1784592000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To evaluate age-specific measles antibody dynamics and identify population immunity gaps in Youyang County, China, approximately two decades after the introduction of a two-dose measles-containing vaccine (MCV) schedule at 8 and 18\u202fmonths of age.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A cross-sectional serosurvey was conducted among residents without rash in 2025. Measles-specific IgG antibodies were quantified using enzyme-linked immunosorbent assay (ELISA), with seroprevalence defined as &amp;gt;200 mIU\/mL. Seroprevalence and geometric mean concentrations (GMCs) were analyzed across eight age strata.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Among 608 participants, the crude overall seroprevalence was 76.5% (IPW-adjusted rate: 81.5%), with significant age-specific variation (\n                      <jats:italic>p<\/jats:italic>\n                      \u202f&amp;lt;\u202f0.001). The lowest levels were observed in infants aged &amp;lt;8\u202fmonths (36.5, 95%CI: 26.2\u201347.9; GMC: 120.47 mIU\/mL). Following two vaccine doses, peak immunity was achieved in children aged 18\u202fmonths to &amp;lt;6\u202fyears (&amp;gt;95%; GMC: 730.99\u20131044.61 mIU\/mL). Seroprevalence then reached a distinct nadir in adults aged 18\u2013&amp;lt;40\u202fyears (65.6, 95% CI: 50.9\u201377.9; GMC: 330.48 mIU\/mL), before rebounding in older adults aged \u226540\u202fyears (90.1\u201393.5%).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This investigation revealed a distinct immunity gap, with measles adjusted seroprevalence at 36.5% (95% CI: 26.2\u201347.9) in infants under 8\u202fmonths and 65.6% (95% CI: 50.9\u201377.9) in reproductive-aged adults, despite robust post-vaccination responses in young children. This serological pattern may be a common characteristic in populations that complete two-dose MCV immunization by 18\u202fmonths of age and experience persistently low measles incidence.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fpubh.2026.1888095","type":"journal-article","created":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T05:34:35Z","timestamp":1784612075000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Age-stratified serosurvey reveals immunity patterns against measles in Youyang, China"],"prefix":"10.3389","volume":"14","author":[{"given":"Siyu","family":"Chen","sequence":"first","affiliation":[{"name":"Beijing Key Laboratory of Core Technologies for the Prevention and Treatment of Emerging Infectious Diseases in Children, Key Laboratory of Major Diseases in Children, Ministry of Education, National Key Discipline of Pediatrics, National Clinical Center for Pediatric Infectious and Allergic Disease Surveillance, National Clinical Research Center for Respiratory Diseases, Laboratory of Infection and Microbiology, Beijing Pediatric Research Institute, Beijing Children\u2019s Hospital, Capital Medical University, National Center for Children\u2019s Health","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianlan","family":"Wang","sequence":"additional","affiliation":[{"name":"Clinical Laboratory, Youyang Hospital, A Branch of The First Affiliated Hospital of Chongqing Medical University","place":["Chongqing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaiwei","family":"Liu","sequence":"additional","affiliation":[{"name":"Beijing Key Laboratory of Core Technologies for the Prevention and Treatment of Emerging Infectious Diseases in Children, Key Laboratory of Major Diseases in Children, Ministry of Education, National Key Discipline of Pediatrics, National Clinical Center for Pediatric Infectious and Allergic Disease Surveillance, National Clinical Research Center for Respiratory Diseases, Laboratory of Infection and Microbiology, Beijing Pediatric Research Institute, Beijing Children\u2019s Hospital, Capital Medical University, National Center for Children\u2019s Health","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Wang","sequence":"additional","affiliation":[{"name":"Beijing Key Laboratory of Core Technologies for the Prevention and Treatment of Emerging Infectious Diseases in Children, Key Laboratory of Major Diseases in Children, Ministry of Education, National Key Discipline of Pediatrics, National Clinical Center for Pediatric Infectious and Allergic Disease Surveillance, National Clinical Research Center for Respiratory Diseases, Laboratory of Infection and Microbiology, Beijing Pediatric Research Institute, Beijing Children\u2019s Hospital, Capital Medical University, National Center for Children\u2019s Health","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Shi","sequence":"additional","affiliation":[{"name":"Beijing Key Laboratory of Core Technologies for the Prevention and Treatment of Emerging Infectious Diseases in Children, Key Laboratory of Major Diseases in Children, Ministry of Education, National Key Discipline of Pediatrics, National Clinical Center for Pediatric Infectious and Allergic Disease Surveillance, National Clinical Research Center for Respiratory Diseases, Laboratory of Infection and Microbiology, Beijing Pediatric Research Institute, Beijing Children\u2019s Hospital, Capital Medical University, National Center for Children\u2019s Health","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoping","family":"Cheng","sequence":"additional","affiliation":[{"name":"Clinical Laboratory, Youyang Hospital, A Branch of The First Affiliated Hospital of Chongqing Medical University","place":["Chongqing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaihu","family":"Yao","sequence":"additional","affiliation":[{"name":"Beijing Key Laboratory of Core Technologies for the Prevention and Treatment of Emerging Infectious Diseases in Children, Key Laboratory of Major Diseases in Children, Ministry of Education, National Key Discipline of Pediatrics, National Clinical Center for Pediatric Infectious and Allergic Disease Surveillance, National Clinical Research Center for Respiratory Diseases, Laboratory of Infection and Microbiology, Beijing Pediatric Research Institute, Beijing Children\u2019s Hospital, Capital Medical University, National Center for Children\u2019s Health","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,21]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.vaccine.2017.07.066","article-title":"Measles vaccines: WHO position paper, April 2017-recommendations","volume":"37","year":"2019","journal-title":"Vaccine"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"100669","DOI":"10.1016\/j.lanwpc.2022.100669","article-title":"China has the momentum to eliminate measles","volume":"30","author":"Durrheim","year":"2023","journal-title":"Lancet Reg Health West Pac."},{"key":"ref3","doi-asserted-by":"publisher","first-page":"861","DOI":"10.3390\/v17060861","article-title":"A comparison of vaccination policies and immunity assessment for measles control: insights from the United States and Japan","volume":"17","author":"Otani","year":"2025","journal-title":"Viruses"},{"key":"ref4","year":"2020"},{"key":"ref5","year":"2020"},{"key":"ref6","year":"2025"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"48","DOI":"10.15585\/mmwr.mm7504a1","article-title":"Measles outbreak associated with an infectious traveler\u2014Colorado, may-June 2025","volume":"75","author":"Metz","year":"2026","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"102887","DOI":"10.1016\/j.jiph.2025.102887","article-title":"Post-pandemic outbreak of measles seen in Japan, 2024","volume":"18","author":"Amemiya","year":"2025","journal-title":"J Infect Public Health"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"219","DOI":"10.7883\/yoken.JJID.2024.207","article-title":"Report on the measles outbreak case in a medical institution in South Korea, 2024","volume":"78","author":"Cho","year":"2025","journal-title":"Jpn J Infect Dis"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.15585\/mmwr.mm6848a2","article-title":"Progress toward measles elimination\u2014China, January 2013-June 2019","volume":"68","author":"Ma","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref11","year":"2026"},{"key":"ref12","year":"2026"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"106531","DOI":"10.1016\/j.jinf.2025.106531","article-title":"The waning of maternal measles antibodies: a multi-country maternal-infant seroprevalence study","volume":"91","author":"Tiley","year":"2025","journal-title":"J Infect"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"446","DOI":"10.3389\/fimmu.2014.00446","article-title":"Maternal antibodies: clinical significance, mechanism of interference with immune responses, and possible vaccination strategies","volume":"5","author":"Niewiesk","year":"2014","journal-title":"Front Immunol"},{"key":"ref15","year":"2021"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1093\/oxfordjournals.aje.a112510","article-title":"Estimating prevalence from the results of a screening test","volume":"107","author":"Rogan","year":"1978","journal-title":"Am J Epidemiol"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"8040","DOI":"10.1016\/j.vaccine.2020.09.076","article-title":"Does education about local vaccination rates and the importance of herd immunity change US parents' concern about measles?","volume":"38","author":"Griffith","year":"2020","journal-title":"Vaccine"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"939","DOI":"10.13200\/j.cnki.cjb.004537","article-title":"Surveillance of measles, rubella and mumps antibody levels in healthy population in Pudong new area of Shanghai from 2018 to 2022","volume":"38","author":"Yang","year":"2025","journal-title":"Chin J Biol"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"714","DOI":"10.13668\/j.issn.1006-9070.2024.06.012","article-title":"Levels of antibodies against measles, rubella and mumps among healthy populations in Nantong City from 2019 to 2023","volume":"35","author":"Gao","year":"2024","journal-title":"Jiangsu J Prev Med"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"107882","DOI":"10.1016\/j.ijid.2025.107882","article-title":"Sero-epidemiology of measles immunoglobulin G antibodies among newborns from South-East Asia and sub-Saharan Africa: an observational, multicenter study","volume":"154","author":"Bokop","year":"2025","journal-title":"Int J Infect Dis"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"555","DOI":"10.3390\/vaccines13060555","article-title":"Comparative analysis of long-term measles immune response after natural infection and routine vaccination in China","volume":"13","author":"Zhao","year":"2025","journal-title":"Vaccines (Basel)"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"4203","DOI":"10.1080\/21645515.2021.1924522","article-title":"One single-center serological survey on measles, rubella and mumps antibody levels of people in Youyang, China","volume":"17","author":"Wang","year":"2021","journal-title":"Hum Vaccin Immunother"}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2026.1888095\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T05:34:37Z","timestamp":1784612077000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2026.1888095\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,21]]},"references-count":22,"alternative-id":["10.3389\/fpubh.2026.1888095"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2026.1888095","relation":{},"ISSN":["2296-2565"],"issn-type":[{"value":"2296-2565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,21]]},"article-number":"1888095"}}